Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Safety of Oral Bisphosphonates in Moderate-to-Severe Chronic Kidney Disease: A Binational Cohort Analysis.

Journal article

Robinson DE. et al, (2021), J bone miner res, 36, 820 - 832

Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease: a propensity score-matched cohort study.

Journal article

Robinson DE. et al, (2021), Health technol assess, 25, 1 - 106

Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease: a propensity score-matched cohort study.

Journal article

Robinson DE. et al, (2021), Health technol assess, 25, 1 - 106

CARDIOVASCULAR RISK FACTORS AND INCIDENCE OF CARDIOVASCULAR EVENTS IN POSTMENOPAUSAL WOMEN AT HIGH RISK OF FRACTURE

Conference paper

Elhussein L. et al, (2020), Osteoporosis international, 31, S552 - S552

Three strategies to measure frailty and/or complex health needs in real world data: An analysis of UK primary care and hospital linked data

Conference paper

Elhussein L. et al, (2020), Pharmacoepidemiology and drug safety, 29, 283 - 284